| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $2,901,248 ) |
| | 2025 | 2025 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | R01DK131488 | Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics | 000 | 4 | NIH | 7/16/2025 | $535,092 |
| | 2025 | 2025 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | R01HL166508 | Mathematical Model-Based Optimization of CRT Response in Ischemia | 000 | 3 | NIH | 7/25/2025 | $771,198 |
| | 2025 | 2025 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | R01DK125657 | Defecation mechanisms and subtyping of constipation patients with Fecobionics | 000 | 5 | NIH | 7/22/2025 | $543,904 |
| | 2025 | 2025 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | R01HL160997 | Mechanisms of coronary flow heterogeneity: Implications for coronary sinus occlusion therapy | 000 | 4 | NIH | 8/5/2025 | $681,054 |
| | 2025 | 2025 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | R01DK134689 | Fecobionics monitoring and prediction of biofeedback therapy outcome in patients with obstructed defecation. | 000 | 3 | NIH | 4/28/2025 | $370,000 |
| | 2025 | 2024 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 001 | 1 | NIH | 4/3/2025 | $0 |
| | 2025 | 2024 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 000 | 1 | NIH | 10/10/2024 | $0 |
| | 2025 | 2024 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 001 | 1 | NIH | 4/3/2025 | $0 |
| | 2025 | 2024 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 003 | 1 | NIH | 8/13/2025 | $0 |
| | 2025 | 2024 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 003 | 1 | NIH | 8/13/2025 | $0 |
| | 2025 | 2024 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 000 | 1 | NIH | 10/10/2024 | $0 |
| | 2025 | 2020 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 002 | 1 | NIH | 8/13/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $3,765,012 ) |
| | 2024 | 2024 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | R01DK134689 | Fecobionics monitoring and prediction of biofeedback therapy outcome in patients with obstructed defecation. | 000 | 2 | NIH | 3/21/2024 | $333,000 |
| | 2024 | 2024 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | R01DK134689 | Fecobionics monitoring and prediction of biofeedback therapy outcome in patients with obstructed defecation. | 001 | 2 | NIH | 5/20/2024 | $22,200 |
| | 2024 | 2024 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | R01DK125657 | Defecation mechanisms and subtyping of constipation patients with Fecobionics | 001 | 4 | NIH | 8/8/2024 | $647,580 |
| | 2024 | 2024 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 002 | 1 | NIH | 8/9/2024 | $625,095 |
| | 2024 | 2024 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | R01DK131488 | Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics | 000 | 3 | NIH | 7/17/2024 | $652,851 |
| | 2024 | 2024 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | R01HL166508 | Mathematical Model-Based Optimization of CRT Response in Ischemia | 000 | 2 | NIH | 6/28/2024 | $765,101 |
| | 2024 | 2024 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | R01HL160997 | Mechanisms of coronary flow heterogeneity: Implications for coronary sinus occlusion therapy | 000 | 3 | NIH | 6/17/2024 | $667,433 |
| | 2024 | 2024 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 002 | 1 | NIH | 8/9/2024 | $51,752 |
| | 2024 | 2023 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 000 | 1 | NIH | 6/6/2024 | $0 |
| | 2024 | 2023 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 000 | 1 | NIH | 6/6/2024 | $0 |
| | 2024 | 2023 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | R01DK125657 | Defecation mechanisms and subtyping of constipation patients with Fecobionics | 000 | 3 | NIH | 5/8/2024 | $0 |
| | 2024 | 2020 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC | 11107 ROSELLE ST STE 211 | SAN DIEGO | IN | 92121-1206 | | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 001 | 1 | NIH | 8/9/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $3,817,307 ) |
| | 2023 | 2023 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC. | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | R01HL166508 | Mathematical Model-Based Optimization of CRT Response in Ischemia | 000 | 1 | NIH | 6/5/2023 | $811,994 |
| | 2023 | 2023 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC. | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | R01HL160997 | Mechanisms of coronary flow heterogeneity: Implications for coronary sinus occlusion therapy | 000 | 2 | NIH | 7/11/2023 | $681,054 |
| | 2023 | 2023 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC. | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 002 | 1 | NIH | 8/14/2023 | $31,130 |
| | 2023 | 2023 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC. | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 002 | 1 | NIH | 8/14/2023 | $645,879 |
| | 2023 | 2023 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC. | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | R01DK125657 | Defecation mechanisms and subtyping of constipation patients with Fecobionics | 000 | 3 | NIH | 6/9/2023 | $559,894 |
| | 2023 | 2023 | CALIFORNIA MEDICAL INNOVATIONS INSTITUTE STE | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | R01DK134689 | Fecobionics monitoring and prediction of biofeedback therapy outcome in patients with obstructed defecation. | 000 | 1 | NIH | 2/24/2023 | $370,000 |
| | 2023 | 2023 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC. | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | R01DK131488 | Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics | 000 | 2 | NIH | 5/26/2023 | $717,356 |
| | 2023 | 2022 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC. | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 000 | 1 | NIH | 6/14/2023 | $0 |
| | 2023 | 2020 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC. | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 001 | 1 | NIH | 8/14/2023 | $0 |
| | 2023 | 2019 | THE CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC. | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | OT2OD028203 | Neurophysiological mechanism in sacral neuromodulation in patients suffering from fecal incontinence | 000 | 1 | NIH | 6/2/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $2,616,759 ) |
| | 2022 | 2022 | CALIFORNIA MEDICAL INNOVATIONS INSTITUTE STE | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | R01DK125657 | Defecation mechanisms and subtyping of constipation patients with Fecobionics | 000 | 2 | NIH | 8/18/2022 | $645,543 |
| | 2022 | 2022 | CALIFORNIA MEDICAL INNOVATIONS INSTITUTE STE | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | R01DK131488 | Pathophysiology, diagnosis and biofeedback therapy in fecal incontinence using fecobionics | 000 | 1 | NIH | 7/25/2022 | $762,766 |
| | 2022 | 2022 | CALIFORNIA MEDICAL INNOVATIONS INSTITUTE STE | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 002 | 1 | NIH | 9/2/2022 | $507,896 |
| | 2022 | 2022 | CALIFORNIA MEDICAL INNOVATIONS INSTITUTE STE | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | R01HL160997 | Mechanisms of coronary flow heterogeneity: Implications for coronary sinus occlusion therapy | 000 | 1 | NIH | 6/14/2022 | $700,554 |
| | 2022 | 2021 | CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC., THE | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 000 | 1 | NIH | 4/1/2022 | $0 |
| | 2022 | 2021 | CALIFORNIA MEDICAL INNOVATIONS INSTITUTE STE | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | OT2OD028203 | Neurophysiological mechanism in sacral neuromodulation in patients suffering from fecal incontinence | 001 | 1 | NIH | 7/11/2022 | $0 |
| | 2022 | 2020 | CALIFORNIA MEDICAL INNOVATIONS INSTITUTE STE | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | OT2OD030213 | SODA - Desktop Software to Enhance the SPARC Data Curation Workflow | 001 | 1 | NIH | 9/1/2022 | $0 |
| | 2022 | 2019 | CALIFORNIA MEDICAL INNOVATIONS INSTITUTE STE | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | OT2OD028203 | Neurophysiological mechanism in sacral neuromodulation in patients suffering from fecal incontinence | 000 | 1 | NIH | 7/8/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $2,831,065 ) (Continued on the next page) |
| | 2021 | 2021 | CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC., THE | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | OT2OD028203 | Neurophysiological mechanism in sacral neuromodulation in patients suffering from fecal incontinence | 005 | 1 | NIH | 7/27/2021 | $0 |
| | 2021 | 2021 | CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC., THE | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | OT2OD028203 | Neurophysiological mechanism in sacral neuromodulation in patients suffering from fecal incontinence | 004 | 1 | NIH | 7/23/2021 | $755,154 |
| | 2021 | 2021 | CALIFORNIA MEDICAL INNOVATIONS INSTITUTE, INC., THE | 11107 ROSELLE ST | SAN DIEGO | CA | 92121-1206 | SAN DIEGO | USA | R01DK125657 | Defecation mechanisms and subtyping of constipation patients with Fecobionics | 000 | 1 | NIH | 6/4/2021 | $645,591 |
|
